Learning Outcomes:

• Be aware of the new regulatory requirements for valproate & topiramate.
• Have a greater understanding of the role of both secondary and primary care clinicians in managing patients prescribed valproate or topiramate across SWL.
• Be aware of the baseline SWL primary care audit data for both valproate and topiramate.
• Understand which resources are being developed for use in primary and secondary care.

Speakers:

Sarah Taylor - Deputy Chief Pharmacist Medicines Use & Safety

Tony Jamieson - Patient Safety Specialist & Clinical Improvement Lead. Medicines Safety Improvement Programme, NHS England

Dr Hannah Cock - Consultant Neurologist, Professor of Epilepsy & Medical Education. St George’s Hospital

Sophia Khan - Senior Primary Care Pharmacist (Medicines Use & Safety)

Dr Nicola Williams – Wandsworth GP

Mental health specialist